Vijayalakshmi Shanmugam

Author

Translational Genomics Research Institute

Also Known As

Partin, Alan W., V. K. Shanmugam, V. Shanmugam, Vijayalakshmi Shanmugam

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Translational Genomics Research Institute McGill University Eunice Kennedy Shriver National Institute of Child Health and Human Development Harvard University Hôpital Notre-Dame

About

Vijayalakshmi Shanmugam is an author at Translational Genomics Research Institute specializing in medicine, gene expression, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	174
2	Cell Biology	2	2	93
3	Natural Sciences	1	1	41
4	Allergy	1	1	32
5	Cellular Physiology	1	1	41

Vijayalakshmi Shanmugam

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Germline Mutations in <i>HOXB13</i> and Prostate-Cancer Risk Charles M. Ewing, Anna M. Ray, Ethan M. Lange, New England Journal of Medicine	2012	656
Osteopontin: Its Transglutaminase-Catalyzed Posttranslational Modifications and Cross-Linking to Fibronectin1 Simone Beninati, Donald R. Senger, Eleonora Cordella‐Miele, The Journal of Biochemistry	1994	85
Calcium-Binding Properties of Osteopontin Derived from Non-Osteogenic Sources1 Krishna Singh, Dave Deonarine, Vijayalakshmi Shanmugam, The Journal of Biochemistry	1993	55
Transgenic expression of an expanded (GCG)13 repeat PABPN1 leads to weakness and coordination defects in mice Patrick A. Dion, Vijayalakshmi Shanmugam, Cláudia Gaspar, Neurobiology of Disease Knockout MouseGenetic DisorderGeneticsCoordination DefectsTransgenic Expression	2005	52
Phase I study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemias Raoul Tibes, Kevin T. McDonagh, Lazaros J. Lekakis, Investigational New Drugs Hematological MalignancyAdvanced LeukemiasAkt Inhibitor TerameprocolMedicineImmunology	2014	49
PABP2 polyalanine tract expansion causes intranuclear inclusions in oculopharyngeal muscular dystrophy Vijayalakshmi Shanmugam, Patrick A. Dion, Daniel Rochefort, Annals of Neurology PathologyMolecular BiologyCytoskeletonCellular PhysiologyProtein Expression	2000	41
Altered Sialylation of Osteopontin Prevents Its Receptor-Mediated Binding on the Surface of Oncogenically Transformed tsB77 Cells Vijayalakshmi Shanmugam, Isaac Chackalaparampil, Gopal C. Kundu, Biochemistry	1997	41
A comparison of immunometric and radioimmunoassay measurement of ACTH for the differential diagnosis of Cushing’s syndrome John R. Lindsay, Vijayalakshmi Shanmugam, Edward H. Oldfield, Journal of Endocrinological Investigation Cushing ’Adrenal GlandAutoimmune DiseaseAllergyMedicine	2006	32
Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer Yoganand Balagurunathan, David L. Morse, Galen Hostetter, Molecular Cancer Therapeutics	2008	26
Whole genome sequencing reveals potential targets for therapy in patients with refractory KRASmutated metastatic colorectal cancer Vijayalakshmi Shanmugam, Ramesh K. Ramanathan, Nicole Lavender, BMC Medical Genomics	2014	20

Page 1